Literature DB >> 8836133

Melanotransferrin gene expression in melanoma cells is correlated with high levels of Jun/Fos family transcripts and with the presence of a specific AP1-dependent ternary complex.

A Rozé-Heusse1, M L Houbiguian, C Debacker, M M Zakin, N Duchange.   

Abstract

The involvement of the transcription factor AP1 in the regulation of melanotransferrin (MTf) gene expression was investigated. MTf, also known as p97, is a tumour-associated antigen that is overproduced in most melanomas. Its gene expression is under the control of an enhancer element containing two AP1 binding sites. By Northern analysis, we demonstrate that MTf mRNA is detected at various levels in melanoma SK-MEL-28 cells and that its greatest expression coincides with the presence of large amounts of jun and fos transcripts. Gel retardation assays revealed that the induction of expression of these proto-oncogenes is correlated with increased AP1 binding activity and that a region of the MTf enhancer is involved in the formation of a ternary AP1-dependent complex, implicating a second nuclear factor whose binding characteristics are similar to those of nuclear factor of activated T cells (NF-AT). In transient expression experiments, the activity resulting from ternary complex formation was high and specific to melanoma cells. These data provide a possible explanation for the mechanisms of AP1 factor family involvement in MTf up-regulation in melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836133      PMCID: PMC1217700          DOI: 10.1042/bj3180883

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

Review 1.  FK506 in the treatment of inflammatory skin disease: promises and perspectives.

Authors:  G Michel; L Kemeny; B Homey; T Ruzicka
Journal:  Immunol Today       Date:  1996-03

2.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

4.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

5.  Molecular basis of sun-induced premature skin ageing and retinoid antagonism.

Authors:  G J Fisher; S C Datta; H S Talwar; Z Q Wang; J Varani; S Kang; J J Voorhees
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

6.  Regulation of melanotransferrin gene in melanoma cells. Analysis of the enhancer region.

Authors:  A Rozé; M M Zakin; N Duchange
Journal:  Biochim Biophys Acta       Date:  1995-02-21

7.  Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.

Authors:  J P Brown; R G Woodbury; C E Hart; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c.

Authors:  P N Cockerill; A G Bert; F Jenkins; G R Ryan; M F Shannon; M A Vadas
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

9.  Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence.

Authors:  T M Rose; G D Plowman; D B Teplow; W J Dreyer; K E Hellström; J P Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  A novel iron uptake mechanism mediated by GPI-anchored human p97.

Authors:  M L Kennard; D R Richardson; R Gabathuler; P Ponka; W A Jefferies
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.